Cell based therapies for ischemic stroke: From basic science to bedside.

Highlights: [•] Cell therapy is emerging as a viable neurorestorative therapy for stroke. [•] Various cell sources have displayed the feasibility and therapeutic efficacy in stroke. [•] Cell-instructed bystander effects presumably underlie the improvement in functional outcome. [•] Several genetic or pharmaceutical pretreatment may enhance the efficacy of cell therapies. [ABSTRACT FROM AUTHOR]